Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 28, 2024; 30(12): 1714-1726
Published online Mar 28, 2024. doi: 10.3748/wjg.v30.i12.1714
Table 4 Univariate and multivariate analysis of overall survival
Risk factorsUnivariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Age (yr)1.044 (1.036-1.051)< 0.01a1.038 (1.030-1.046)< 0.01a
Sex (female/male)0.861 (0.730-1.015)0.074
BMI (kg/m2)0.959 (0.935-0.984)0.001a0.997 (0.972-1.023)0.840
T2DM (yes/no)1.303 (1.038-1.636)0.022a0.941 (0.745-1.189)0.610
Tumor site (colon/ rectum)1.422 (1.091-1.853)0.009a0.984 (0.831-1.165)0.851
Tumor stage (IV/III/II/I)2.202 (1.979-2.452)< 0.01a2.167 (1.943-2.416)< 0.01a
Smoking (yes/no)1.081 (0.918-1.273)0.351
Drinking (yes/no)1.070 (0.901-1.271)0.438
Hypertension (yes/no)1.055 (0.879-1.266)0.564
CHD (yes/no)1.355 (0.939-1.957)0.105
Tumor size (≥ 5 cm/< 5 cm)1.532 (1.305-1.799)< 0.01a1.235 (1.044-1.459)0.014a
RDW (lower/higher)0.664 (0.565-0.780)< 0.01a0.925 (0.774-1.107)0.396
Hematocrit (lower/higher)1.693 (1.437-1.995)< 0.01a1.256 (1.041-1.515)0.017a
Overall complications (yes/no)1.903 (1.611-2.248)< 0.01a1.608 (1.357-1.904)< 0.01a